• Jitendra Kumar P School of Pharmaceutical Education and Research,Berhampuruniversity,Brahampur 760007 ,Odisha, India.
  • Gitanjali Misra


In the present study, an attempt was made to develop the pulsatile drug delivery of fluvastatin sodium to the colon. Formaldehyde-treated capsule
bodies were used for the preparation of pulsincaps. It was sealed with a unhardened cap of the capsule. The microspheres were prepared by emulsion
solvent evaporation technique. Optimized microsphere formulations were selected based on dissolution studies. Hydrogel plug (HP) (Karaya gum and
lactose in 1:1 ratio) having 4.5 kg/cm
hardness and 100 mg weight was placed in the capsule opening and found that it was satisfactory to retard the
drug release in small intestinal fluid and to eject out the plugin colonic fluid and releasing the microspheres into colonic fluid after a lag time criterion
of 5 hrs. The sealed capsules were completely coated by dip coating method with 5% cellulose acetate phthalate to prevent variable gastric emptying.
Dissolution studies of pulsatile capsule device in media with different pH (1.2, 7.4 and 6.8) showed that drug release in the colon could be modulated
by optimizing the concentration of polymers in the microspheres. Drug-polymer interaction studies indicated no interaction in between the drug and
the polymer. Among all the formulations, fluvastatin sodium microspheres prepared with Eudragit RS 100 in 1:3 ratio shown prolonged release for a
period of 12 hrs. The obtained results showed the capability of the system in delaying drug release for a programmable period of time and to deliver
the drug in the early morning hours when cholesterol synthesis are more prevalent.
Keywords: Fluvastatin sodium, Pulsatile, Hydrogel plug.



Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit

Rev Ther Drug Carrier Syst 2001;18(5):433-58.

Jones PJ, Schoeller DA. Evidence for diurnal periodicity in human

cholesterol synthesis. J Lipid Res 1990;31(4):667-73.

Kamal SM. Effects of single-dose morning and evening administration

of pravastatin on antioxidant markers in cholesterol-fed rabbits. J Exp

Pharmacol 2011;3:51-8.

Goff WL, Guerin M, Chapman J, Bruckert E. Circadian and inter

individual variations of cholesterol synthesis. Sang Thromb Vaiss


Toda T, Eliasson E, Ask B, Inotsume N, Rane A. Roles of different CYP

enzymes in the formation of specific fluvastatin metabolites by human

liver microsomes. Basic Clin Pharmacol Toxicol 2009;105(5):327-32.

Sukanya M, Sai Kishore V. Design and development of

chronopharmaceutical drug delivery of simvastatin. J Chem Pharm Res


Sai Kishore V, Ramesh B, Lakshmana Rao R. Design and development

of pulsincap for chronopharmaceutical drug delivery losartan

potassium. Asian J Pharm Res Dev 2014;2(3):78-86.

Pandey JK, Indira Muzib Y, Misra G. Preparation and evaluation

of pulsatile drug delivery of lovastatin. Int J Pharm Sci Rev Res


Sandeep M, Sai Kishore V, Sudheer B, Ershad S, Adithya K,

Phanilkumar DS. Design and development of chronopharmaceutical

drug delivery of lansoprazole. Asian J Pharm Res Dev 2013;1(5):1-9.

Jagdalea SC, Phulea PS, Chavan GJ. Formulation and evaluation of

modified pulsincap drug delivery system of rizatriptan benzoate. Int J

Pharm PharmSci 2014;6(5):48-52.

Gupta S, Munjal T, Bhatia P, Kaur I. Fabrication and evaluation

of fluvastatin sodium loaded sustained release microspheres using

polymer blends. Int J Pharm Pharm Sci 2014;6(5):365-71.

Sai Kishore V, Sandeep M, Sudheer B. Preparation and evaluation of

chronopharmaceutical drug delivery of lansoprazole. Res Rev J Pharm

Pharm Sci 2013;2(4):45-55.



How to Cite

Kumar P, J., . I. M. . Y, and G. Misra. “PREPARATION AND EVALUATION OF PULSATILE DRUG DELIVERY OF FLUVASTATIN SODIUM”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 2, Mar. 2016, pp. 348-51,



Original Article(s)